Novartis: all 3,900 studies
Page 14 of 39. Open to participants first (226), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes MellitusCompletedNCT01171976Phase 3Results posted
- Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic ArthritisCompletedNCT01169844Phase 2Results posted
- 24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance Renal Transplant RecipientsCompletedNCT01169701Phase 4Results posted
- Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive PatientsCompletedNCT01167153Phase 4Results posted
- Zoledronic Acid in MS-patients With OsteoporosisTerminatedNCT01166178Phase 3Results posted
- Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly SubjectsCompletedNCT01162122Phase 3Results posted
- To Determine the Safety, Tolerability, Pharmacokinetics and Effect on Pain of a Single Intra-articular Administration of Canakinumab in Patients With Osteoarthritis in the KneeCompletedNCT01160822Phase 2Results posted
- A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast CancerCompletedNCT01160211Phase 3Results posted
- Efficacy, Safety and Pharmacokinetics of Different Regimens of IndacaterolCompletedNCT01156844Phase 2Results posted
- A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention (PCI) (CHAMPION PHOENIX)CompletedNCT01156571Phase 3Results posted
- Effect of NVA237 on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01154127Phase 3Results posted
- Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2010-2011CompletedNCT01152814Phase 2Results posted
- An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of AgeCompletedNCT01151410Phase 3Results posted
- Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of AgeCompletedNCT01150357Phase 3Results posted
- Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy WomenCompletedNCT01150123Phase 1Results posted
- Extension Study to Evaluate the Long-term Efficacy and Safety of Everolimus in Liver Transplant RecipientsCompletedNCT01150097Phase 3Results posted
- Efficacy and Tolerability of BAF312 in Patients With Polymyositis and DermatomyositisTerminatedNCT01148810Phase 2Results posted
- Assessment of Antibody Persistence at Eighteen Months After the Completion of the Vaccination Course in Study V72P10CompletedNCT01148524Phase 2/3Results posted
- Comparison of Safety, Effectiveness and Quality of Life Outcomes Between Labeled Versus "Treat and Extend" Regimen in Turkish Patients With Choroidal Neovascularisation Due to Age-related Macular Degeneration (AMD)CompletedNCT01148511Phase 4Results posted
- Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate VaccineCompletedNCT01148017Phase 3Results posted
- Pazopanib Versus Sunitinib in the Treatment of Asian Subjects With Locally Advanced and/or Metastatic Renal Cell CarcinomaCompletedNCT01147822Phase 2Results posted
- One Year Antibody Persistence After a Fourth Dose Boost or Two Catch-Up Doses of Novartis Meningococcal B Recombinant Vaccine Administered Starting From 12 Months of Age and Response to a Third Dose Boost or Two Catch-Up Doses Starting at 24 Months of AgeCompletedNCT01139021Phase 3Results posted
- Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled AcromegalyCompletedNCT01137682Phase 3Results posted
- Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)CompletedNCT01135914Phase 3Results posted
- Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast CancerTerminatedNCT01132664Phase 1/2Results posted
- AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe PsoriasisCompletedNCT01132612Phase 2Results posted
- Safety and Efficacy of Ranibizumab in Diabetic Macular EdemaTerminatedNCT01131585Phase 3Results posted
- Study of Nilotinib in Ph+ CML-CP Patients With Low Imatinib Trough Plasma ConcentrationsTerminatedNCT01131325Phase 4Results posted
- Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer PatientsCompletedNCT01129336Phase 4Results posted
- A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MBCompletedNCT01125800Phase 1/2Results posted
- A Study to Investigate the Pharmacodynamic and Pharmacokinetic Interaction Between Aliskiren and Furosemide in Patients With Heart FailureCompletedNCT01125514Phase 2Results posted
- A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy.CompletedNCT01124864Phase 2Results posted
- Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old)CompletedNCT01123941Phase 1Results posted
- A Study to Assess the Long-term Safety of QVA149CompletedNCT01120717Phase 3Results posted
- Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) ExacerbationsCompletedNCT01120691Phase 3Results posted
- Efficacy and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01119950Phase 2Results posted
- Long Term Safety and Tolerability of NVA237 Versus Tiotropium in Japanese PatientsCompletedNCT01119937Phase 3Results posted
- Extension to QTI571A2301 to Evaluate the Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH)TerminatedNCT01117987Phase 3Results posted
- Efficacy, Safety and Evolution of Cardiovascular Parameters in Renal Transplant RecipientsCompletedNCT01114529Phase 3Results posted
- Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing SpondylitisCompletedNCT01109940Phase 2Results posted
- Safety and Efficacy of AIN457 in Patients With Active Non-infectious UveitisTerminatedNCT01095250Phase 3Results posted
- 38 Week Extension Study to CAIN457C2303TerminatedNCT01093846Phase 3Results posted
- Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO).CompletedNCT01090323Phase 2Results posted
- Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious UveitisTerminatedNCT01090310Phase 3Results posted
- Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01089127Phase 3Results posted
- European Ambulance Acute Coronary Syndrome (ACS) Angiography TrialCompletedNCT01087723Phase 3Results posted
- Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple MyelomaCompletedNCT01083602Phase 2Results posted
- Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 YearsCompletedNCT01082367Phase 3Results posted
- Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With HypertensionTerminatedNCT01080768Phase 2Results posted
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study.CompletedNCT01080131Phase 3Results posted
- Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant RecipientsCompletedNCT01079143Phase 3Results posted
- Efficacy and Safety of Different Doses of IndacaterolCompletedNCT01079130Phase 3Results posted
- A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)CompletedNCT01077544Phase 1Results posted
- Ofatumumab Bendamustine Combination Compared With Bendamustine Monotherapy in Indolent B-cell NHL Unresponsive to RituxtherapyTerminatedNCT01077518Phase 3Results posted
- 12-week Efficacy of IndacaterolCompletedNCT01072448Phase 3Results posted
- Investigate Safety, Pharmacokinetics and Pharmacodynamics of GSK2118436 & GSK1120212CompletedNCT01072175Phase 2Results posted
- A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type PsoriasisCompletedNCT01071252Phase 2Results posted
- To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan AloneCompletedNCT01070043Phase 4Results posted
- Second Open Label Extension to Bridging Study CTBM100C2303CompletedNCT01069705Phase 3Results posted
- To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes TherapiesCompletedNCT01068860Phase 2Results posted
- Comparison of Efficacy of Indacaterol Versus Placebo Over 12 WeeksCompletedNCT01068600Phase 3Results posted
- Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney CancerCompletedNCT01064310Phase 3Results posted
- Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome & /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic PhaseCompletedNCT01061177Phase 4Results posted
- A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With LymphangioleiomyomatosisCompletedNCT01059318Phase 2Results posted
- Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza Study.CompletedNCT01056822Phase 4Results posted
- POC-MD MRI-based Trial in Relapsing-remitting Multiple SclerCompletedNCT01051817Phase 2Results posted
- Study to Evaluate Nilotinib in Chronic Myelogenous Leukemia (CML) Patients With SubOptimal ResponseCompletedNCT01043874Phase 4Results posted
- Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive PatientsCompletedNCT01042392Phase 4Results posted
- Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction TherapyTerminatedNCT01039376Phase 3Results posted
- A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic RhinitisCompletedNCT01038427Phase 3Results posted
- Proof of Concept Study Efficacy of an Antacid/Lansoprazole Combination for Relief of HeartburnCompletedNCT01037452Phase 2Results posted
- This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart FailureTerminatedNCT01035255Phase 3Results posted
- Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma.CompletedNCT01035229Phase 3Results posted
- LBH589 Alone or in Combination With Erythropoietin Stimulating Agents (ESA) in Patients With Low or Int-1 Risk Myelodysplastic Syndromes (MDS)TerminatedNCT01034657Phase 2Results posted
- A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL)CompletedNCT01034163Phase 3Results posted
- Safety and Efficacy of Deferasirox in Patients With Transfusion Dependent Iron Overload - a Non-comparative Extension StudyCompletedNCT01033747Phase 2/3Results posted
- To Evaluate the Safety, Local Tolerability, PK and PD of LDE225 on Sporadic Superficial and Nodular Skin Basal Cell Carcinomas (sBCC)TerminatedNCT01033019Phase 2Results posted
- Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious UveitisTerminatedNCT01032915Phase 3Results posted
- Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin SecretionCompletedNCT01030952Phase 4Results posted
- Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine Including a 12 Weeks Extension and an Open-label 48 Weeks Extension StudyCompletedNCT01029652Phase 3Results posted
- A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit MutationCompletedNCT01028222Phase 2Results posted
- Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of Booster Doses of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received One or Four Doses of the Same VaccineCompletedNCT01027351Phase 2Results posted
- Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of a Booster Dose of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received Three Doses of the Same VaccineCompletedNCT01026974Phase 2Results posted
- Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant RecipientsCompletedNCT01025817Phase 3Results posted
- Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids.CompletedNCT01023815Phase 3Results posted
- Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple MyelomaCompletedNCT01023308Phase 3Results posted
- Safety and Preliminary Efficacy of MOR103 in Patients With Active Rheumatoid ArthritisCompletedNCT01023256Phase 1/2Results posted
- Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment.CompletedNCT01022996Phase 2Results posted
- Efficacy of Diclofenac Potassium Versus Acetaminophen in Febrile Children With Acute Upper Respiratory Tract InfectionsTerminatedNCT01019980Phase 4Results posted
- A Study to Evaluate the Persistence and Immune Response to a Booster Dose of MenACWYCompletedNCT01018732Phase 2Results posted
- Everolimus in de Novo Heart Transplant RecipientsCompletedNCT01017029Phase 4Results posted
- Lapatinib in Combination With VinorelbineCompletedNCT01013740Phase 2Results posted
- Effect of Indacaterol on Inspiratory Capacity (IC)CompletedNCT01012765Phase 3Results posted
- Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Maleate Via Concept1 or Simoon DevicesCompletedNCT01012739Phase 2Results posted
- An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's DiseaseTerminatedNCT01009281Phase 2Results posted
- Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast CancerCompletedNCT01007942Phase 3Results posted
- Effect of Omalizumab in Patients With Severe Persistent Non-atopic Uncontrolled AsthmaCompletedNCT01007149Phase 3Results posted
- A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus PlaceboCompletedNCT01005901Phase 3Results posted
- Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential HypertensionCompletedNCT01001572Phase 3Results posted
- A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 MonthsCompletedNCT01000311Phase 3Results posted